IL6 and systemic sclerosis: While IL-6 plays a critical role in a wide variety of pathophysiologic processes, excessive production of this cytokine in SSc results in increased collagen production through fibroblast activation, myofibroblast differentiation, and inhibition of secretion of matrix metalloproteinases that carry collagenolytic activity responsible for tissue repair and collagen turnover [69].